Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ROLE of ParoXetine in Patients Taking Telaprevir-based Hepatitis C Therapy: Lack of a Drug-drug Interaction? (ROLEX)

NCT01841502 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01841502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01841502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ROLE of ParoXetine in Patients Taking Telaprevir-based Hepatitis C Therapy: Lack of a Drug-drug Interaction? (ROLEX)
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2013
Completion date
September 30, 2014
Enrollment
3 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

depression, hepatitis c infection